GO TO 
FOLLOW US
  • Facebook Social Icon
  • Twitter Social Icon

CE Mark Approval for Shift Labs’ DripAssist Infusion Rate Monitor

February 7, 2017

 

Three months ago we sat down with Dr. Beth Kolko, CEO of Shift Labs, to learn more about DripAssist Infusion Rate Monitor, a device that automates the calculation of IV infusion drip rates and total infusion volumes while also being able to alert a nurse when a drip rate changes or stops. At that time, DripAssist had already been FDA approved. At the end of last month, Shift Labs completed another regulatory milestone by securing CE Mark approval for DripAssist. Following this announcement, European Union member countries will now be able to benefit from accurate medication dosing as well as infusion time and cost savings that DripAssist has already been able to deliver in over 15 countries...

 

 

View Artcle Here

Please reload

About Us

Shift Labs creates well-designed devices for fast-growing healthcare sectors, everywhere from home health care in the US to clinical care in emerging markets. We emphasize both design and technology to create devices that help a diverse range of healthcare workers to provide better care in more places.

  • Facebook Social Icon
  • LinkedIn Social Icon
  • Twitter Social Icon
PHYSICAL ADDRESS

Shift Labs, Inc.

9200 Holman rd NW

Seattle, WA 98117 USA

Email: info@shiftlabs.com
Tel:  +1 206.369.1216

STAY UP TO DATE WITH OUR NEWSLETTERS